VYNE Therapeutics annual meeting elects directors, ratifies auditor, approves say-on-pay

VYNE Therapeutics Inc.

Class I directors Elisabeth Sandoval Little and Steven Basta elected with ~3.9M votes each.
Baker Tilly US, LLP ratified as independent auditor for FY 2024 with 15.3M votes for.
Advisory vote on named executive officer compensation passed with 4.6M votes for.
Quorum of 50.1% of 33.3M shares outstanding at meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.